STOCK TITAN

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ironwood Pharmaceuticals (Nasdaq: IRWD) announces that CFO Sravan Emany will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 6, 2024, at 9:00 a.m. ET. The event will take place at the Marriott Marquis in New York City. A live webcast of the session will be available on the Investors section of Ironwood's website, and a replay will be accessible for one year post-event.

Positive
  • Ironwood Pharmaceuticals is gaining visibility by participating in a major healthcare conference.
  • The event will be webcast live, increasing transparency and accessibility for investors.
  • Replay availability for one year allows prolonged access for stakeholders to review the discussion.
Negative
  • No direct financial or clinical data updates were provided in this announcement, offering immediate business impact.
  • Participation in conferences does not guarantee positive stock performance and can sometimes be seen as routine rather than newsworthy.

BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City.

A live webcast of Ironwood’s fireside chat will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 1 year following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap 600® company, is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). LINZESS is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years-old. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure (SBS-IF), as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.

Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, with a site in Basel, Switzerland.

We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on Twitter and on LinkedIn.

Investors:

Greg Martini, 617-374-5230

gmartini@ironwoodpharma.com

Matt Roache, 617-621-8395

mroache@ironwoodpharma.com

Media:

Beth Calitri, 978-417-2031

bcalitri@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

When will Ironwood Pharmaceuticals participate in the Jefferies Global Healthcare Conference?

Ironwood Pharmaceuticals will participate in the Jefferies Global Healthcare Conference on June 6, 2024, at 9:00 a.m. ET.

Who will represent Ironwood Pharmaceuticals at the Jefferies Global Healthcare Conference?

Sravan Emany, the Chief Financial Officer of Ironwood Pharmaceuticals, will represent the company.

Where will the Jefferies Global Healthcare Conference take place?

The conference will take place at the Marriott Marquis in New York City.

Will there be a live webcast of Ironwood Pharmaceuticals’ session at the Jefferies Global Healthcare Conference?

Yes, a live webcast will be available on the Investors section of Ironwood's website.

How long will the replay of Ironwood Pharmaceuticals’ fireside chat be available?

The replay will be available on Ironwood’s website for one year following the conference.

Ironwood Pharmaceuticals, Inc. -

NASDAQ:IRWD

IRWD Rankings

IRWD Latest News

IRWD Stock Data

718.11M
157.19M
1.68%
105.28%
5.35%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BOSTON